약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 12.

Antimicrobial susceptibility analysis criteria for E. coli (MICs, CLSI guideline)

Antimicrobial MICs (ug/mL)
S I R
Amoxicillin/clavulanic acid S≤8/4 I =16/8 R≥32/16
Cefepime S≤2 I =4-8 R≥16
Cefoxitin S≤8 I =16 R≥32
Trimethoprim/sulfamethoxazole S≤2/38 - R≥4/76
Chloramphenicol S≤8 I =16 R≥32
Ampicillin S≤8 I =16 R≥32
Ciprofloxacin S≤0.25 I =0.5 R≥1
Gentamicin S≤4 I =8 R≥16
Ceftazidime S≤4 I =8 R≥16
Tetracyclin S≤4 I =8 R≥16
Sulfisoxazole S≤256 - R≥512
Nalidixic Acid S≤16 - R≥32
Meropenem S≤1 I =2 R≥4
Ertapenem S≤0.5 I =1 R≥2
Imipenem S≤1 I =2 R≥4
Meropenem S≤1 I =2 R≥4
Doripenem S≤1 I =2 R≥4
Yakhak Hoeji 2024;68:168-209 https://doi.org/10.17480/psk.2024.68.3.168
© 2024 Yakhak Hoeji